Playlist
President of Turkmenistan Attends Official Dinner at Akasaka Palace in Tokyo
20 Dec. 10:36During his official visit to Japan, President of Turkmenistan Serdar Berdimuhamedov took part in a formal state dinner held at the Akasaka Palace in Tokyo. The event formed an important element of the diplomatic agenda of Turkmenistan’s head of state in the Japanese capital.
Earlier in the day, the President of Turkmenistan held a series of high-level meetings in Tokyo, including discussions with members of the Japanese Parliament, executives of major Japanese corporations, and an audience with the Emperor of Japan. These engagements highlighted the growing political and economic cooperation between Turkmenistan and Japan.
Following the meetings, the presidential motorcade of Turkmenistan arrived at Akasaka Palace, where President Berdimuhamedov was warmly welcomed by the Prime Minister of Japan. On behalf of the Prime Minister and his spouse, an official dinner was hosted in honor of the leaders of Central Asian countries, underscoring Turkmenistan’s constructive role in regional diplomacy.
The working visit of the President of Turkmenistan to Japan is ongoing, reflecting Turkmenistan’s strategic commitment to strengthening international partnerships.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz